COVID-19 public health emergency to end May 11, 2023

With one of the two national emergencies addressing COVID-19 brought to a close earlier in April and the other set to expire on May 11, 2023, some changes are coming to Purdue University and Purdue Global health plans. 

Beginning May 12, 2023:

COVID-19 vaccine: The COVID-19 vaccine will be covered the same as other seasonal vaccines and boosters. The plan will pay 100% with no member cost share.

Over-the-counter (OTC) COVID-19 tests: OTC COVID-19 tests will no longer be covered under the health plan; however, FSA and HSA funds can still be used to purchase at-home testing kits. 

COVID-19 testing via in-network provider: COVID-19 testing administered by an in-network health care provider will be covered; deductible and coinsurance will apply.

Dispensing of COVID-19 oral antivirals (Paxlovid and Molnupiravir): No change to coverage. These drugs will continue to be covered at $0 cost share until further notice.

COVID-19 monoclonal antibodies: No change in coverage. Only administered by a medical provider.

See the U.S. Department of Health and Human Services Fact Sheet for details. 

More information

You may qualify for free COVID testing kits through the U.S. Department of Health and Human Services.

Sign up for a free kit here: https://www.covid.gov/tests.

Questions about Purdue and Purdue Global health plan coverage can be directed to Human Resources at hr@purdue.edu or by phone at 765-494-2222 or toll-free at 877-725-0222.